Ann: SIRFLOX ASCO Abstract Released, page-31

Yes, my mistake; you're absolutely right and as usual the professional analysts are regurgitating rubbish - I should have guessed. For clarity, this is what SRX said:

"Sirtex anticipates that important new information will arise from the Oral Abstract Session that facilitates a greater understanding of the implications and impact of the SIRFLOX study for SIR- Spheres® Y-90 resin microspheres in first-line mCRC, and how this may apply to clinical practice."

In other words they hope that someone else who attends the Oral Abstract Session will have a bright idea which might be good for Sirtex sales! Quite a bit different from the interpretation given by Roger Montgomery hacks.